Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Proflavine hemisulphate is the hemisulfate salt of proflavine, an acridine-derived compound used primarily as a topical antiseptic and disinfectant. It acts as a bacteriostatic agent against many gram-positive bacteria and is applied to superficial wounds, cuts, grazes, insect bites, and burns to prevent infection. Its mechanism of action involves intercalation into DNA base pairs, disrupting DNA synthesis and leading to mutations that inhibit bacterial reproduction. Proflavine also functions as a fluorescent contrast agent in high-resolution optical imaging for visualizing cell nuclei in diagnostic procedures. Due to its toxicity and carcinogenicity in mammals, its use is restricted mainly to topical applications[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on proflavine hemisulphate.